Schedule 13D ownership disclosure

SOLID BIOSCIENCES INC COM NEW

Common Stock, $0.001 par value per share · CUSIP: 83422E105

Event date: 2025-02-19

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • BCLS SB Investco, LPReported CIK 0001728056

    Shares: 528,660 · Class: 0.7%

  • Bain Capital Life Sciences Fund II, L.P.Reported CIK 0001773187

    Shares: 267,257 · Class: 0.3%

  • BCLS II Investco, LPReported CIK 0001818893

    Shares: 6,179,042 · Class: 7.8%

  • BCIP Life Sciences Associates, LPReported CIK 0001702921

    Shares: 32,550 · Class: 0.04%

  • BCLS II Equity Opportunities, LPReported CIK 0001814474

    Shares: 904,160 · Class: 1.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-025036
Form type
SCHEDULE 13D/A
Filer
BCLS SB Investco, LP
CIK
CIK 1728056
Filed
Feb 21, 2025
Reporting period
Feb 19, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub